1 NATIONAL GENE TECHNOLOGY REGULATORY SYSTEM Key achievements during this quarter The key achievements of the 1 January to 31 March 2015 quarter were: Licences and other instruments 2 licences issued for Dealings involving the Intentional Release (DIR) of GMOs into the environment 1 licence issued for Dealings Not involving the Intentional Release (DNIR) of GMOs into the environment 17 physical containment facilities certified 24 instruments surrendered 49 certifications, four DIR licences and 10 DNIR licences varied. Further information on licences and other instruments is contained in Section 2 of this report. Monitoring and Compliance Approximately 15 per cent of current field trial sites and eight per cent of post-harvest field trial sites were subjected to routine monitoring during the quarter. This exceeds the target minimum rate of five per cent of all field trial sites per quarter. Further information on monitoring and compliance is contained in Section 2 of this report. Working collaboratively with States and Territories Legislative and Governance Forum on Gene Technology The Legislative and Governance Forum on Gene Technology (LGFGT) oversees the implementation of the regulatory system and comprises one Minister from the Commonwealth and one Minister from each of the States and Territories. Currently, the LGFGT includes Ministers from a range of portfolios including health, agriculture and environment. State and Territory consultation The Regulator must consult with State and Territory Governments and appropriate local councils during the evaluation of applications for all DIR licences. For each application for a DIR licence other than a limited and controlled release, the Regulator is required to seek advice on matters relevant to the preparation of the Risk Assessment and Risk Management Plan (RARMP), and must also seek comment on
1 NATIONAL GENE TECHNOLOGY REGULATORY SYSTEM Key achievements during this quarter The key achievements of the 1 January to 31 March 2015 quarter were: Licences and other instruments 2 licences issued for Dealings involving the Intentional Release (DIR) of GMOs into the environment 1 licence issued for Dealings Not involving the Intentional Release (DNIR) of GMOs into the environment 17 physical containment facilities certified 24 instruments surrendered 49 certifications, four DIR licences and 10 DNIR licences varied. Further information on licences and other instruments is contained in Section 2 of this report. Monitoring and Compliance Approximately 15 per cent of current field trial sites and eight per cent of post-harvest field trial sites were subjected to routine monitoring during the quarter. This exceeds the target minimum rate of five per cent of all field trial sites per quarter. Further information on monitoring and compliance is contained in Section 2 of this report. Working collaboratively with States and Territories Legislative and Governance Forum on Gene Technology The Legislative and Governance Forum on Gene Technology (LGFGT) oversees the implementation of the regulatory system and comprises one Minister from the Commonwealth and one Minister from each of the States and Territories. Currently, the LGFGT includes Ministers from a range of portfolios including health, agriculture and environment. State and Territory consultation The Regulator must consult with State and Territory Governments and appropriate local councils during the evaluation of applications for all DIR licences. For each application for a DIR licence other than a limited and controlled release, the Regulator is required to seek advice on matters relevant to the preparation of the Risk Assessment and Risk Management Plan (RARMP), and must also seek comment on